Karen L. Elkins - Search Results

Year	Number of Results
2002	3
2003	5
2004	1
2005	1
2006	2
2007	3
2008	5
2009	7
2010	4
2011	3
2012	2
2013	4
2014	3
2015	2
2016	4
2017	1
2018	2
2019	2
2020	5
2021	3
2022	1
2023	4
2024	2

1

Progress, challenges, and opportunities in Francisella vaccine development.

Elkins KL, Kurtz SL, De Pascalis R. Elkins KL, et al. Expert Rev Vaccines. 2016 Sep;15(9):1183-96. doi: 10.1586/14760584.2016.1170601. Epub 2016 May 3. Expert Rev Vaccines. 2016. PMID: 27010448 Review.

2

Immunity to Francisella.

Cowley SC, Elkins KL. Cowley SC, et al. Among authors: elkins kl. Front Microbiol. 2011 Feb 16;2:26. doi: 10.3389/fmicb.2011.00026. eCollection 2011. Front Microbiol. 2011. PMID: 21687418 Free PMC article.

3

Innate and adaptive immunity to Francisella.

Elkins KL, Cowley SC, Bosio CM. Elkins KL, et al. Ann N Y Acad Sci. 2007 Jun;1105:284-324. doi: 10.1196/annals.1409.014. Epub 2007 Apr 27. Ann N Y Acad Sci. 2007. PMID: 17468235 Review.

4

Innate and adaptive immune responses to an intracellular bacterium, Francisella tularensis live vaccine strain.

Elkins KL, Cowley SC, Bosio CM. Elkins KL, et al. Microbes Infect. 2003 Feb;5(2):135-42. doi: 10.1016/s1286-4579(02)00084-9. Microbes Infect. 2003. PMID: 12650771 Free article. Review.

5

Working correlates of protection predict SchuS4-derived-vaccine candidates with improved efficacy against an intracellular bacterium, Francisella tularensis.

De Pascalis R, Frey B, Rice HM, Bhargava V, Wu TH, Peterson RL, Conlan JW, Sjöstedt A, Elkins KL. De Pascalis R, et al. Among authors: elkins kl. NPJ Vaccines. 2022 Aug 17;7(1):95. doi: 10.1038/s41541-022-00506-9. NPJ Vaccines. 2022. PMID: 35977964 Free PMC article.

6

Sequence comparison of Francisella tularensis LVS, LVS-G and LVS-R.

Kurtz SL, Voskanian-Kordi A, Simonyan V, Elkins KL. Kurtz SL, et al. Among authors: elkins kl. Pathog Dis. 2018 Oct 1;76(7). doi: 10.1093/femspd/fty067. Pathog Dis. 2018. PMID: 30137434

7

IL-12p40 is essential but not sufficient for Francisella tularensis LVS clearance in chronically infected mice.

Mittereder LR, Swoboda J, De Pascalis R, Elkins KL. Mittereder LR, et al. Among authors: elkins kl. PLoS One. 2023 Mar 27;18(3):e0283161. doi: 10.1371/journal.pone.0283161. eCollection 2023. PLoS One. 2023. PMID: 36972230 Free PMC article.

8

Infection of mice with Francisella as an immunological model.

Conlan JW, Chen W, Bosio CM, Cowley SC, Elkins KL. Conlan JW, et al. Among authors: elkins kl. Curr Protoc Immunol. 2011 Apr;Chapter 19:Unit 19.14. doi: 10.1002/0471142735.im1914s93. Curr Protoc Immunol. 2011. PMID: 21462168 Free PMC article.

9

Deficiency in CCR2 increases susceptibility of mice to infection with an intracellular pathogen, Francisella tularensis LVS, but does not impair development of protective immunity.

Kurtz SL, De Pascalis R, Meierovics AI, Elkins KL. Kurtz SL, et al. Among authors: elkins kl. PLoS One. 2021 Mar 24;16(3):e0249142. doi: 10.1371/journal.pone.0249142. eCollection 2021. PLoS One. 2021. PMID: 33760886 Free PMC article.

10

Host Genetic Background Influences BCG-Induced Antibodies Cross-Reactive to SARS-CoV-2 Spike Protein.

Specht AG, Ginese M, Kurtz SL, Elkins KL, Specht H, Beamer G. Specht AG, et al. Among authors: elkins kl. Vaccines (Basel). 2024 Feb 26;12(3):242. doi: 10.3390/vaccines12030242. Vaccines (Basel). 2024. PMID: 38543876 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

63 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

63 results

Results by year